HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice.

Abstract
The activation of the death receptors, tumor necrosis factor-receptor-1 (TNF-R1) or CD95, is a hallmark of inflammatory or viral liver disease. In different murine in vivo models, we found that livers depleted of gamma-glutamyl-cysteinyl-glycine (GSH) by endogenous enzymatic conjugation after phorone treatment were resistant against death receptor-elicited injury as assessed by transaminase release and histopathology. In apoptotic models initiated by engagement of CD95, or by injection of TNF or lipopolysaccharide into galactosamine-sensitized mice, hepatic caspase-3-like proteases were not activated in the GSH-depleted state. Under GSH depletion, also caspase-independent, TNF-R1-mediated injury (high-dose actinomycin D or alpha-amanitin), as well as necrotic hepatotoxicity (high-dose lipopolysaccharide) were entirely blocked. In the T-cell-dependent model of concanavalin A-induced hepatotoxicity, GSH depletion resulted in a suppression of interferon-gamma release, delay of systemic TNF release, hepatic nuclear factor-kappaB activation, and an abrogation of sinusoidal endothelial cell detachment as assessed by electron microscopy. When GSH depletion was initiated 3 hours after concanavalin A injection, ie, after the peak of early pro-inflammatory cytokines, livers were still protected. We conclude that sufficient hepatic GSH levels are a prerequisite for the execution of death receptor-mediated hepatocyte demise.
AuthorsH Hentze, F Gantner, S A Kolb, A Wendel
JournalThe American journal of pathology (Am J Pathol) Vol. 156 Issue 6 Pg. 2045-56 (Jun 2000) ISSN: 0002-9440 [Print] United States
PMID10854226 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amanitins
  • Antigens, CD
  • Cytokines
  • Nucleic Acid Synthesis Inhibitors
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I
  • Concanavalin A
  • Dactinomycin
  • Caspases
  • Glutathione
Topics
  • Amanitins (pharmacology)
  • Animals
  • Antigens, CD (metabolism)
  • Apoptosis (physiology)
  • Caspases (physiology)
  • Cell Death (physiology)
  • Concanavalin A (pharmacology)
  • Cytokines (metabolism)
  • Dactinomycin (pharmacology)
  • Dose-Response Relationship, Drug
  • Glutathione (deficiency)
  • Liver (drug effects, metabolism, pathology, physiology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Necrosis
  • Nucleic Acid Synthesis Inhibitors (pharmacology)
  • Receptors, Tumor Necrosis Factor (metabolism, physiology)
  • Receptors, Tumor Necrosis Factor, Type I
  • Shock, Septic (mortality, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: